keyword
https://read.qxmd.com/read/38377530/transformable-magnetic-liquid-metal-nanoplatform-for-intracellular-drug-delivery-and-mr-imaging-guided-microwave-thermochemotherapy
#1
JOURNAL ARTICLE
Zonghao Liu, Weikun Li, Xin Tan, Yueru Huang, Yinghua Tao, Ning Yang, Renqiang Yuan, Ling Liu, Liqin Ge
Improved techniques for the administration of chemotherapeutic drugs are required to enhance tumor therapy efficacy and reduce the side effects of chemotherapy due to insufficient targeting and limited intratumoral drug release. Controlled drug delivery systems combined with thermotherapy are expected to play an important role in personalized tumor therapy. Herein, a novel microwave-responsive transformable magnetic liquid-metal (MLM) nanoplatform is designed for effective endosomal escape that facilitates intracellular drug delivery and enhanced anticancer therapy...
February 20, 2024: ACS Applied Materials & Interfaces
https://read.qxmd.com/read/38329573/intravesical-thermochemotherapy-in-the-treatment-of-high-risk-and-very-high-risk-non-muscle-invasive-urothelial-bladder-cancer-a-single-arm-study
#2
JOURNAL ARTICLE
Antonín Brisuda, Jakub Horňák, Barbora Žemličková, Jaromír Háček, Marek Babjuk
AIM: Intravesical thermochemotherapy, also known as HIVEC (Hyperthermic Intra-VEsical Chemotherapy), represents an alternative adjuvant topical treatment for non-muscle-invasive urothelial bladder cancer (NMIBC). High-risk (HR) and very HR tumors carry a substantial risk of recurrence and progression. In this study, we present our own results using HIVEC as an alternative to unavailable Bacillus Calmette-Guérin (BCG) vaccine in the treatment of such groups of patients. METHODS: During the period of November 2014-June 2022, a total of 47 patients with HR and very HR NMIBC underwent treatment with HIVEC after transurethral resection...
February 8, 2024: International Urology and Nephrology
https://read.qxmd.com/read/37563954/use-of-s2-2-dox-magnetic-nanoliposomes-in-mr-molecule-imaging-and-targeted-thermochemotherapy-for-breast-cancer-in-vitro
#3
JOURNAL ARTICLE
Yinxing Zhu, Dazhuang Yang, Ting Guo, Mei Lin
OBJECTIVE: To prepare S2.2/DOX magnetic nanoliposomes by combining the potential benefits of MNPs in MRI and the targeted performance of nano-drugs as an innovative method for integrated diagnosis and treatment of breast cancer (BC). METHODS: We created a S2.2-PEG-MZF/DOX molecular probe by using a lipid material to encapsulate PEG-MZF-NPs and doxorubicin (DOX), and a S2.2 aptamer to target MUC1 to conjugate with PEG-MZF/DOX nanoliposomes. The potential of probe for cell-specific targeting and magnetic resonance (MR) molecular imaging was evaluated by MR scanner and Prussian blue staining...
2023: Technology in Cancer Research & Treatment
https://read.qxmd.com/read/37545170/ros-sp1-axis-is-involved-in-thermochemotherapy-enhanced-sensitivity-of-pancreatic-cancer-cells-to-gemcitabine
#4
JOURNAL ARTICLE
Pan Xi, Xiaojuan Ma, Fuquan Hu, Liang Li, Huijuan Liu, Jing Zhou, Wenan Wu
Gemcitabine (GEM)-based chemotherapy represents the first choice for locally unresectable advanced pancreatic cancer, while the benefit is limited due to acquired chemoresistance or drug delivery insufficiency. Hyperthermia treatment potentially improves the clinical efficacy of GEM. However, the underlying mechanism is incompletely revealed. Our study aims to investigate the effect and involved mechanism of thermochemotherapy on cell survival. Pancreatic cancer cells PANC-1 and ASPC-1 were either treated with GEM or thermochemotherapy, then cell viability, apoptosis, migration, invasion, reactive oxygen species (ROS) production, and Sp1 expression were evaluated...
August 6, 2023: Cell Biology International
https://read.qxmd.com/read/36906430/-evaluation-of-the-efficacy-and-safety-of-hivec-intravesical-thermochemotherapy-with-intermediate-risk-and-high-risk-non-muscle-invasive-bladder-cancer
#5
JOURNAL ARTICLE
A Cimier, S Thach, B Lacroix, C Mariat
INTRODUCTION: Non-muscle-infiltrating cancers (NMIBC) represent 75% of bladder tumors. The objective of our study is to report a single-center experience of the efficacy and tolerability of HIVEC on intermediate- and high-risk NMIBC in adjuvant therapy. MATERIAL AND METHOD: Between December 2016 and October 2020, patients with intermediate-risk or high-risk NMIBC were included. They were all treated with HIVEC as an adjuvant therapy to bladder resection. Efficacy was assessed by endoscopic follow-up and tolerance by a standardized questionnaire...
March 9, 2023: Progrès en Urologie
https://read.qxmd.com/read/36609947/transmissible-h-aggregated-nir-ii-fluorophore-to-the-tumor-cell-membrane-for-enhanced-ptt-and-synergistic-therapy-of-cancer
#6
JOURNAL ARTICLE
Haoli Yu, Yuesong Wang, Yan Chen, Mengyuan Cui, Fang Yang, Peng Wang, Min Ji
Photothermal therapy (PTT) combined with second near-infrared (NIR-II) fluorescence imaging (FI) has received increasing attention owing to its capacity for precise diagnosis and real-time monitoring of the therapeutic effects. It is of great clinical value to study organic small molecular fluorophores with both PTT and NIR-II FI functions. In this work, we report a skillfully fluorescent lipid nanosystem, the RR9 (RGDRRRRRRRRRC) peptide-coated anionic liposome loaded with organic NIR-II fluorophore IR-1061 and chemotherapeutic drug carboplatin, which is named RRIALP-C4...
January 6, 2023: Nano Convergence
https://read.qxmd.com/read/36269742/the-clinical-efficacy-and-safety-of-equipment-assisted-intravesical-instillation-of-mitomycin-c-after-transurethral-resection-of-bladder-tumour-in-patients-with-nonmuscular-invasive-bladder-cancer-a-meta-analysis
#7
JOURNAL ARTICLE
Weijian Zhou, Jianping Liu, Dongdong Mao, Changying Hu, Dianjun Gao
BACKGROUND: This review and meta-analysis aimed to systematically evaluate the clinical efficacy and safety of equipment-assisted intravesical instillation of mitomycin C (MMC) in patients with nonmuscular invasive bladder cancer (NMIBC) after transurethral resection of bladder tumour (TURBT). METHODS: The Embase, PubMed, CNKI, CBM, WANGFANG, VIP, Cochrane Library, and Clinicaltrial.com databases were searched for articles published before April 2022. The experimental group was treated with intravesical instillation of MMC assisted by equipment, including radiofrequency-induced thermochemotherapy, conductive thermochemical therapy, electromotive drug administration, or locoregional hyperthermia...
2022: PloS One
https://read.qxmd.com/read/35571421/hyperthermia-enhances-the-efficacy-of-chemotherapeutic-drugs-in-heat-sensitive-cells-through-interfering-with-dna-damage-repair
#8
JOURNAL ARTICLE
Li-Ping Ni, Hua-Ting Sun, Ping Wang, Juan Wang, Jin-Hua Zhou, Ruo-Qi Cao, Ling Yue, You-Guo Chen, Fang-Rong Shen
Background: Hyperthermic intraperitoneal chemotherapy (HIPEC) has been shown to be clinically effective, but the mechanisms by which hyperthermia enhances the sensitivity of cells to chemotherapeutic drugs has not yet been elucidated. Methods: To identify the key molecules involved in thermochemotherapy, this study used mass spectrometry (MS)-based quantitative proteomics technology to analyze the effects of thermochemotherapy on the heat-sensitive ovarian cancer cell line A2780...
April 2022: Annals of Translational Medicine
https://read.qxmd.com/read/34689763/an-intelligent-responsive-macrophage-cell-membrane-camouflaged-mesoporous-silicon-nanorod-drug-delivery-system-for-precise-targeted-therapy-of-tumors
#9
JOURNAL ARTICLE
Minghua Li, Xiaolong Gao, Chao Lin, Aijun Shen, Jing Luo, Qiongqiong Ji, Jiaqi Wu, Peijun Wang
Macrophage cell membrane-camouflaged nanocarriers can effectively reduce immune cell clearance and actively target tumors. In this study, a macrophage cell membrane-camouflaged mesoporous silica nanorod (MSNR)-based antitumor drug carrier equipped with a cationic polymer layer was developed. As drug carriers, these MSNRs were loaded with the thermosensitive phase change material L-menthol (LM), the chemotherapy drug doxorubicin (DOX) and the fluorescent molecule indocyanine green (ICG). The rod-like shape of the MSNRs was shown to enhance the penetration of the drug carriers to tumors...
October 24, 2021: Journal of Nanobiotechnology
https://read.qxmd.com/read/34599207/computational-modeling-of-thermal-combination-therapies-by-magneto-ultrasonic-heating-to-enhance-drug-delivery-to-solid-tumors
#10
JOURNAL ARTICLE
Mohammad Souri, Madjid Soltani, Farshad Moradi Kashkooli
For the first time, inspired by magnetic resonance imaging-guidance high intensity focused ultrasound (MR-HIFU) technology, i.e., medication therapy and thermal ablation in one session, in a preclinical setting based on a developed mathematical model, the performance of doxorubicin (Dox) and its encapsulation have been investigated in this study. Five different treatment methods, that combine medication therapy with mild hyperthermia by MRI contrast ([Formula: see text]) and thermal ablation via HIFU, are investigated in detail...
October 1, 2021: Scientific Reports
https://read.qxmd.com/read/34499769/hsp70-promotes-tumor-progression-by-stabilizing-skp2-expression-in-gastric-cancer-cells
#11
JOURNAL ARTICLE
Ziying Lei, Xiaohong Xia, Qiaoling He, Jiali Luo, Yan Xiong, Jin Wang, Hongsheng Tang, Tianpei Guan, Yun Tian, Songhui Xu, Shuzhong Cui
Gastric cancer (GC) has one of the highest tumor incidences worldwide. Heat shock protein 70 (HSP70) is highly expressed and plays a critical role in the occurrence, progression, metastasis, poor prognosis, and drug resistance of GC. However, the underlying mechanisms of HSP70 are not clear. To explore the regulatory role of HSP70 in GC, we performed cell counting kit-8 (CCK-8) and EdU staining assays to assess cell proliferation; immunohistochemistry and western blot analyses to assess protein expression; coimmunoprecipitation (Co-IP) assays to assess interactions between two proteins; and immunofluorescence to assess protein expression and localization...
December 2021: Molecular Carcinogenesis
https://read.qxmd.com/read/34499486/correction-to-cu-2-loaded-polydopamine-nanoparticles-for-magnetic-resonance-imaging-guided-ph-and-near-infrared-light-stimulated-thermochemotherapy
#12
Rui Ge, Min Lin, Xing Li, Shuwei Liu, Wenjing Wang, Shuyao Li, Xue Zhang, Yi Liu, Lidi Liu, Feng Shi, Hongchen Sun, Hao Zhang, Bai Yang
No abstract text is available yet for this article.
September 9, 2021: ACS Applied Materials & Interfaces
https://read.qxmd.com/read/34186412/self-targeting-nanotherapy-based-on-functionalized-graphene-oxide-for-synergistic-thermochemotherapy
#13
JOURNAL ARTICLE
Dao Shi, Jiangyuan Zhuang, Zhongxiong Fan, Hai Zhao, Xin Zhang, Guanghao Su, Liya Xie, Dongtao Ge, Zhenqing Hou
Nanotherapy based on thermochemotherapy has boomed as a promising alternative for oncotherapy due to the enhanced permeability and retention (EPR) effect. However, a lack of self-targeting capacity prevents nanotherapy from efficiently accumulating in tumor tissue and internalizing into tumor cells, resulting in a suboptimal therapeutic effect. To overcome these bottlenecks, a kind of methotrexate (MTX)-soybean phospholipid (SPC) inclusion complex (MTX-SPC)-modified graphene oxide (CGO) nanotherapy (CGO-MTX-SPC) is constructed by CGO nanosheets as a supporter for MTX-SPC, thereby realizing active-targeting and synergistic thermochemotherapy...
June 16, 2021: Journal of Colloid and Interface Science
https://read.qxmd.com/read/33641904/polydopamine-carbon-dots-functionalized-hollow-carbon-nanoplatform-for-fluorescence-imaging-and-photothermal-enhanced-thermochemotherapy
#14
JOURNAL ARTICLE
Junya Lu, Kaili Wang, Wei Lei, Yuling Mao, Donghua Di, Qinfu Zhao, Siling Wang
The low power photothermal therapy can reduce the tissue damage caused by laser irradiation, thus the near-infrared (NIR) absorbing vehicles with high photothermal conversion efficiency are demanded in the low power treatment. Herein, the NIR-absorbing agent polydopamine (PDA) and carbon dots (CDs) were gated on the openings of hollow mesoporous carbon (HMC) to construct a photothermal enhanced multi-functional system (HMC-SS-PDA@CDs). Interestingly, the fluorescence emission wavelength of HMC-SS-PDA@CDs was red-shifted by FRET effect between PDA and CDs, which solved the dilemma of fluorescence quenching of carbon-based materials and was more conducive to cell imaging...
March 2021: Materials Science & Engineering. C, Materials for Biological Applications
https://read.qxmd.com/read/33105816/hyperthermia-and-temperature-sensitive-nanomaterials-for-spatiotemporal-drug-delivery-to-solid-tumors
#15
REVIEW
Mohamadreza Amin, Wenqiu Huang, Ann L B Seynhaeve, Timo L M Ten Hagen
Nanotechnology has great capability in formulation, reduction of side effects, and enhancing pharmacokinetics of chemotherapeutics by designing stable or long circulating nano-carriers. However, effective drug delivery at the cellular level by means of such carriers is still unsatisfactory. One promising approach is using spatiotemporal drug release by means of nanoparticles with the capacity for content release triggered by internal or external stimuli. Among different stimuli, interests for application of external heat, hyperthermia, is growing...
October 22, 2020: Pharmaceutics
https://read.qxmd.com/read/32384954/thermosensitive-liposomes-encapsulating-anti-cancer-agent-lomustine-and-contrast-medium-iohexol-for-thermochemotherapy-preparation-characterization-and-in-vivo-evaluation
#16
JOURNAL ARTICLE
Shuoye Yang, Wensheng Zhu, Zhenwei Wang, Yongmei Xiao, Pu Mao, Lingbo Qu, Yuansen Hu, Jinshui Wang
Thermosensitive liposome-based drug delivery systems (DDS) are powerful tools for site-specific delivery of chemotherapeutics, especially when combined with regional hyperthermia. The objective of this work was to develop a novel thermosensitive liposomal DDS loaded with lomustine, a chemotherapeutic compound, and iohexol, a contrast medium for visualization by CT. Thermosensitive compound liposomes (TSCLs) composed of DPPC were prepared by reverse-phase evaporation and investigated for encapsulation efficiency, temperature-sensitivity, release kinetics, and In Vivo pharmacokinetics...
October 1, 2020: Journal of Nanoscience and Nanotechnology
https://read.qxmd.com/read/32247801/a-moderate-thermal-dose-is-sufficient-for-effective-free-and-tsl-based-thermochemotherapy
#17
REVIEW
G C van Rhoon, M Franckena, T L M Ten Hagen
Hyperthermia, i.e. heating the tumor to a temperature of 40-43 °C is considered by many a valuable treatment to sensitize tumor cells to radiotherapy and chemotherapy. In recent randomized trials the great potential of adding hyperthermia to chemotherapy was demonstrated for treatment of high risk soft tissue sarcoma: +11.4% 5 yrs. overall survival (OS) and for ovarian cancer with peritoneal involvement nearly +12 months OS gain. As a result interest in combining chemotherapy with hyperthermia, i.e. thermochemotherapy, is growing...
2020: Advanced Drug Delivery Reviews
https://read.qxmd.com/read/32169778/multi-stimuli-responsive-mesoporous-silica-coated-carbon-nanoparticles-for-chemo-photothermal-therapy-of-tumor
#18
JOURNAL ARTICLE
Hongyan Lu, Qinfu Zhao, Xiudan Wang, Yuling Mao, Caishun Chen, Yikun Gao, Changshan Sun, Siling Wang
In this work, a traceable dual-porous mesoporous silica-coated mesoporous carbon nanocomposite (MCN@Si) with high drug loading capacity and high photothermal conversion efficiency (30.5 %) was successfully prepared. Based on the nanocomposite, a pH/redox/near infrared (NIR) multi-stimuli responsive drug delivery system was constructed to realize the accurate drug delivery, drug controlled release and chemo-photothermal synergistic antitumor therapy. MCN@Si was used as a vehicle to load doxorubicin (DOX) with a high drug loading efficacy of 48...
March 4, 2020: Colloids and Surfaces. B, Biointerfaces
https://read.qxmd.com/read/32009384/nir-thermo-responsive-injectable-self-healing-hydrogel-containing-polydopamine-nanoparticles-for-efficient-synergistic-cancer-thermochemotherapy
#19
JOURNAL ARTICLE
Chunyao Wang, Nuoya Zhao, Weizhong Yuan
Injectable and self-healing hydrogels with thermoresponsiveness as the smart hydrogel could achieve the injectability and heal automatically, and the phase and volume changes as well. Here, the thermoresponsive self-healing hydrogel was prepared via the dynamic covalent enamine bonds between the amino groups in polyetherimide (PEI) and the acetoacetate groups in four-armed star-shaped poly(2-(dimethylamino)ethyl methacrylate-co-2-hydroxyethyl methacrylate) modified with tertiary-butyl acetoacetate (t-BAA), SP(DMAEMA-co-HEMA-AA)...
February 3, 2020: ACS Applied Materials & Interfaces
https://read.qxmd.com/read/31824157/preparation-and-characterization-of-fe-3-o-4-mtx-magnetic-nanoparticles-for-thermochemotherapy-of-primary-central-nervous-system-lymphoma-in-vitro-and-in-vivo
#20
JOURNAL ARTICLE
Xinyu Dai, Jingqing Yao, Yuejiao Zhong, Yuntao Li, Qianling Lu, Yan Zhang, Xue Tian, Zhirui Guo, Tingting Bai
Background: Primary central nervous system lymphomas (PCNSL) are extranodal malignant non-Hodgkin lymphomas (NHL) that arise exclusively in central nervous system (CNS). Diffuse large B-cell lymphoma (DLBCL) is the most common histological subtype. Purpose: To evaluate whether nano drug-loading system-mediated magnetic-targeted thermochemotherapy could produce a better therapeutic effect than single chemotherapy while reducing the use of chemotherapeutic drugs. Methods: Six groups (control, Fe3 O4 , MTX, Fe3 O4 @MTX, Fe3 O4 with hyperthermia and Fe3 O4 @MTX with hyperthermia) were set...
2019: International Journal of Nanomedicine
keyword
keyword
42179
1
2
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.